ANTX vs NOC · $32.0M cap vs P/E 17, rev $20.76B
AN2 Therapeutics Inc (ANTX) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
ANTX does not have a complete income-statement cache yet.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
ANTX currently screens at market cap $32.0M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the ANTX and NOC stock pages for the full models.
Not investment advice.